https://www.selleckchem.com/pr....oducts/tocilizumab.h
Treatment with plasmapheresis revealed significantly better renal recovery (p value 0.03) in this group of patients. AKI with background of Hemolytic Uremic Syndrome (HUS) may remain irreversible in many of these young women. Plasmapheresis should be offered to patients with established diagnosis of HUS. AKI with background of Hemolytic Uremic Syndrome (HUS) may remain irreversible in many of these young women. Plasmapheresis should be offered to patients with established diagnosis of HUS. To compare oral Nifidepine and IV labetalol
Like
Comment
Share
